Treating Patients in 2nd Ling Setting after 1st Line Keytruda

Treating Patients in 2nd Ling Setting after 1st Line Keytruda

User Photo
obr

1 year
62 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Pasi A Jänne, MD, Director, Lowe Center for Thoracic Oncology, Belfer Center for Applied Cancer Science, Senior Physician, Professor of Medicine at Harvard Medical School explains how he would treat 2nd line patients who received Keytruda or another PD-L1 targeting agent as part of 1st line therapy.
Up Next Autoplay